NEW YORK ( TheStreet) --

The Washington Post ( WPO) is a popular search topic today following the launch of a new series called "Top Secret America."

The newspaper ran the first article of the series on July 19. Investigative reporters Dana Priest and Bill Arkin aim to reveal information about national security and government activity following 9/11, and expose almost 2,000 of America's top secret organizations.

Shares of the company have swung dramatically over the past several days. The company recently purchased iCurrent, an online tool that lets users collect news according to their interests. The company also partnered with Bloomberg on a new online business section.


"Broadband" is a hot search term today after the U.S. Federal Communications Commission issued a report that put the number of Americans without broadband access at between 14 and 24 million.

"Broadband is critical 21st century infrastructure, to which every American household and small business must have access to maximize our nation's economic growth, catalyze investment, spur job creation and ensure our global competitiveness," said FCC Chairman Julius Genachowski.

The FCC wants to make broadband available to all Americans by reforming its universal service programs to allow broadband for both commercial and unlicensed uses.


"Home construction" and "U.S. real estate" are popular search topics today following recent reports from the Commerce Department and the U.S. Census Bureau putting home construction starts at the lowest level since October 2009.

Housing starts were down in June to 549,000, 5% below the May estimate of 578,000 and 5.8% below the June 2009 rate of 583,000.

Single-family housing starts dropped 0.7% to 454,000 in June from 457,000 in May.


"Breast cancer drug" is among the most searched for phrases today following a vote by a panel of experts from the Food and Drug Administration to remove Avastin from the market. The breast cancer treatment drug is manufactured by Genentech, a subsidiary of the Roche Group.

"We are disappointed by the committee's recommendation and believe Avastin should continue to be an option for women with this incurable disease," said Sandra Horning, M.D., senior vice president and global head of clinical development and hematology/oncology at Roche Group.

The vote doesn't effect the current availability of the drug and the FDA is expected to make a final decision on the drug by September 17.

The chatter on Main Street (a.k.a. Google) is always of interest to investors on Wall Street. Thus, each day, TheStreet compiles the stories that are trending on Google, and highlights the news that could make stocks move.

-- Reported by Theresa McCabe in Boston.

Follow Theresa McCabe on Twitter and become a fan on Facebook.
Copyright 2010 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. AP contributed to this report.